BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
12.58
+0.53 (4.36%)
Dec 19, 2025, 3:15 PM EST - Market open
BBOT Employees
BridgeBio Oncology Therapeutics had 62 employees as of December 31, 2024.
Employees
62
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,853,774
Market Cap
1.01B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BBOT News
- 2 days ago - BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 days ago - BridgeBio Oncology Therapeutics: Promising KRAS Drug Developer - In My View, At Least - Seeking Alpha
- 7 days ago - BBOT Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 days ago - BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS) - GlobeNewsWire
- 4 weeks ago - BBOT to Participate in Upcoming December Investor Healthcare Conferences - GlobeNewsWire
- 5 weeks ago - BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress - GlobeNewsWire
- 6 weeks ago - BBOT to Participate in the Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 7 weeks ago - BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS) - GlobeNewsWire